Alira Health, a global healthcare consulting and research organization, announces the global launch of its innovative technology platform SpherePX, designed to drive real-world evidence (RWE) collection and elevate patient engagement and retention. This platform empowers organizations to seamlessly manage Phase 4 studies and patient registries, including post-authorization safety studies (PASS), effectiveness assessments, and comparative studies.
To further support its expanding technology offerings, Alira Health has appointed Ifti Alli as Vice President of Digital Solutions. Ifti, who brings experience from his work at Experian Health, Medidata, and other health-tech startups, will play a pivotal role in driving Alira Health’s technology solutions to market more broadly.
"SpherePX’s ability to orchestrate patient journeys represents a game-changing innovation for the life sciences industry," says Alira Health’s Chief Strategy Officer, Piergiulio Lauriano. "With its advanced patient-centric design, modular flexibility, and seamless interoperability, the platform enables our partners to generate robust real-world evidence. Under Ifti’s leadership, we are excited to take our technology to the next level."
Key Benefits:
A Vision for Patient-Enabled Healthcare
This innovative technology aligns with Alira Health’s mission of improving the lives of patients globally through innovation and collaboration. Its patient-enabled framework ensures that every study conducted not only meets the needs of stakeholders but also delivers measurable value to the patients who rely on these breakthroughs.
Availability
SpherePX is now available to pharmaceutical and medtech companies worldwide.